EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WITH A POSITIVE COLORECTAL CANCER SCREENIN

EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WITH A POSITIVE COLORECTAL CANCER SCREENING TEST. (SUIVICOLO) is a phase 3, randomised interventional study registered as NCT07520578 by University Hospital, Caen, with a registry enrolment figure of 2000 participants, started 2026-03-24 and due to reach its primary completion in 2027-03-24. Interventions recorded: Usual care follow-up by CRCDC; Information leaflet about colonoscopy follow-up; Endorsement of CRCDC letters from the GP. Conditions listed: Colorectal Cancer Screening. Primary outcome: Colonoscopy rate at 6 months after a positive test. Colorectal eligibility wording from the registry: "* Aged between 50 and 75 at the time of the positive colorectal cancer screening test". Sites: France. No results are recorded here; the registry entry is the source.